Senior practitioners, always
No juniors supervised by absent partners. The people who scope your work build your work — for the first 10–15 clients, that's a permanent commitment, not a launch promise.
About
Nyveon.AI exists because most AI consultancies can do strategy or they can do engineering — rarely both, and almost never at the hardware-to-model level that regulated industries actually need.
Founding Team
Our founding team's experience spans banking and financial services, large-enterprise technology, SaaS product leadership, and platform engineering — AI-first for the portion of that career where AI has been the differentiator, including live clinical-device platforms where a BLE hardware stack streams to an LLM-powered cloud.
That end-to-end, hardware-to-model experience is the backbone of every protocol we publish and every engagement we deliver. Strategy consultants can't audit firmware. Device engineers can't govern models. We do both — which is why PE and VC firms use us for MedTech due diligence no one else can run.
Mission
We publish protocols before we pitch them — Clinical AI Track B and the bidirectional IP Firewall exist as documents anyone can read, not just claims in a sales deck. Buyers should be able to find us, and evaluate us, before we find them.
No juniors supervised by absent partners. The people who scope your work build your work — for the first 10–15 clients, that's a permanent commitment, not a launch promise.
Every claim we make carries a number, an artifact, or a named protocol. We'd rather under-promise on the website and over-deliver on the call.
We're not an Indian firm serving Indian clients — we're a global AI consultancy headquartered in Bengaluru. Talent engine, not a limitation.
Clinical and financial AI carry real stakes. We built our delivery model around a hard human-in-the-loop boundary because that's the responsible way to capture this market — not the only way.